BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2999307)

  • 21. Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses.
    Colonno RJ; Callahan PL; Long WJ
    J Virol; 1986 Jan; 57(1):7-12. PubMed ID: 3001366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle.
    Kaplan G; Levy A; Racaniello VR
    J Virol; 1989 Jan; 63(1):43-51. PubMed ID: 2535745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down regulation of poliovirus receptor RNA in HeLa cells resistant to poliovirus infection.
    Kaplan G; Racaniello VR
    J Virol; 1991 Apr; 65(4):1829-35. PubMed ID: 1705991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44 is not required for poliovirus replication.
    Bouchard MJ; Racaniello VR
    J Virol; 1997 Apr; 71(4):2793-8. PubMed ID: 9060634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
    McDougal JS; Nicholson JK; Cross GD; Cort SP; Kennedy MS; Mawle AC
    J Immunol; 1986 Nov; 137(9):2937-44. PubMed ID: 2428879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A whole cell immunization-derived monoclonal antibody that protects cells from coxsackievirus A9 infection binds to both cell surface and virions.
    Roivainen M; Alakulppi N; Ylipaasto P; Eskelinen M; Paananen A; Airaksinen A; Hovi T
    J Virol Methods; 2005 Dec; 130(1-2):108-16. PubMed ID: 16055201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poliovirus mutants resistant to neutralization with soluble cell receptors.
    Kaplan G; Peters D; Racaniello VR
    Science; 1990 Dec; 250(4987):1596-9. PubMed ID: 2177226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The poliovirus empty capsid specifically recognizes the poliovirus receptor and undergoes some, but not all, of the transitions associated with cell entry.
    Basavappa R; Gómez-Yafal A; Hogle JM
    J Virol; 1998 Sep; 72(9):7551-6. PubMed ID: 9696852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of poliovirus with its receptor affords a high level of infectivity to the virion in poliovirus infections mediated by the Fc receptor.
    Arita M; Horie H; Arita M; Nomoto A
    J Virol; 1999 Feb; 73(2):1066-74. PubMed ID: 9882307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The poliovirus receptor: identification of domains and amino acid residues critical for virus binding.
    Bernhardt G; Harber J; Zibert A; deCrombrugghe M; Wimmer E
    Virology; 1994 Sep; 203(2):344-56. PubMed ID: 7914388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor.
    Mason PW; Baxt B; Brown F; Harber J; Murdin A; Wimmer E
    Virology; 1993 Feb; 192(2):568-77. PubMed ID: 8380665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A monoclonal antibody to the type 1 insulin-like growth factor and insulin receptors stimulates deoxyribonucleic acid synthesis in human and murine fibroblasts.
    Cara JF; Stuart CA; Furlanetto RW
    Endocrinology; 1988 Sep; 123(3):1341-7. PubMed ID: 2969801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccinia virus-mediated expression and identification of the human poliovirus receptor.
    Zibert A; Selinka HC; Elroy-Stein O; Moss B; Wimmer E
    Virology; 1991 May; 182(1):250-9. PubMed ID: 1850905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.
    Yang WX; Terasaki T; Shiroki K; Ohka S; Aoki J; Tanabe S; Nomura T; Terada E; Sugiyama Y; Nomoto A
    Virology; 1997 Mar; 229(2):421-8. PubMed ID: 9126254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses.
    Hsu KH; Lonberg-Holm K; Alstein B; Crowell RL
    J Virol; 1988 May; 62(5):1647-52. PubMed ID: 2451756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes.
    Barel M; Fiandino A; Delcayre AX; Lyamani F; Frade R
    J Immunol; 1988 Sep; 141(5):1590-5. PubMed ID: 2842398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monoclonal antibodies to the antigens of human HeLa tumor cells].
    Malakhova IV; Khizhniakova TM; Novokhatskiĭ AS
    Tsitologiia; 1986 May; 28(5):537-44. PubMed ID: 3526672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional domains of the poliovirus receptor.
    Koike S; Ise I; Nomoto A
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4104-8. PubMed ID: 1851992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody-aided characterization of cellular p220 in uninfected and poliovirus-infected HeLa cells: subcellular distribution and identification of conformers.
    Etchison D; Etchison JR
    J Virol; 1987 Sep; 61(9):2702-10. PubMed ID: 3039164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.